×
0 0 0 0 0 0.0023977620887171 -0.00512854668975629 -0.00648328226988143
Stockreport

Switching course, Gilead markets HIV drug for prevention [FOX News]

GILEAD SCIENCES (GILD)  More Company Research Source: FOX News
Last gilead sciences earnings: 10/26 04:01 pm Check Earnings Report
PDF LU/us.ny.nyc NEW YORK –   NASDAQ-NMS:GILD Gilead Sciences Inc has begun marketing its HIV treatment Truvada in a way thousands of consumers already use it - to prevent infection with the virus that causes AIDS. The company introduced Truvada to [Read more]

IMPACT SNAPSHOT EVENT TIME: GILD
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

-2.82%

GILD's stock demonstrates weak fall of -2.82% from 75.07-share to 72.95-share since news

EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS